Published in Cell Mol Life Sci on December 01, 2003
Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma. Sarcoma (2011) 0.92
Chronic insulin treatment suppresses PTP1B function, induces increased PDGF signaling, and amplifies neointima formation in the balloon-injured rat artery. Am J Physiol Heart Circ Physiol (2008) 0.81
Effect of serum replacement with plysate on cell growth and metabolismin primary cultures of human skeletal muscle. Cytotechnology (2005) 0.79
Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71
Common and interchangeable elements in the promoters of genes transcribed by RNA polymerase iii. Cell (1983) 2.94
Cloning of several cDNA segments coding for human liver proteins. EMBO J (1983) 2.32
Structure and expression of the human haptoglobin locus. EMBO J (1985) 2.09
Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen binding. J Thromb Haemost (2005) 2.02
Anoikis: an emerging hallmark in health and diseases. J Pathol (2012) 1.98
The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase. Nature (1994) 1.95
Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J (2000) 1.86
Conserving large populations of lions - the argument for fences has holes. Ecol Lett (2013) 1.69
Acceleration of the folding of acylphosphatase by stabilization of local secondary structure. Nat Struct Biol (1999) 1.66
HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest (1998) 1.59
Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett (1991) 1.58
Cloning and sequencing of a full length cDNA coding for a human apoferritin H chain: evidence for a multigene family. EMBO J (1984) 1.42
Cloning and sequencing of a full length cDNA coding for human retinol-binding protein. Nucleic Acids Res (1983) 1.36
Insights into acylphosphatase structure and catalytic mechanism. Cell Mol Life Sci (1997) 1.32
Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia (2001) 1.32
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem (2001) 1.32
Sequence of human haptoglobin cDNA: evidence that the alpha and beta subunits are coded by the same mRNA. Nucleic Acids Res (1983) 1.29
Slow folding of muscle acylphosphatase in the absence of intermediates. J Mol Biol (1998) 1.26
Three-dimensional structure of acylphosphatase. Refinement and structure analysis. J Mol Biol (1992) 1.24
Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review). Int J Mol Med (1998) 1.21
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem (2001) 1.19
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ (2008) 1.18
Biodiversity of Aspergillus species in some important agricultural products. Stud Mycol (2007) 1.15
Low molecular weight protein tyrosine phosphatases: small, but smart. Cell Mol Life Sci (2002) 1.15
Conformational stability of muscle acylphosphatase: the role of temperature, denaturant concentration, and pH. Biochemistry (1998) 1.13
Crystal structure of common type acylphosphatase from bovine testis. Structure (1997) 1.13
Structural characterization of the transition state for folding of muscle acylphosphatase. J Mol Biol (1998) 1.13
Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene (2009) 1.13
The inactivation mechanism of low molecular weight phosphotyrosine-protein phosphatase by H2O2. J Biol Chem (1998) 1.11
Expression, purification, and characterization of acylphosphatase muscular isoenzyme as fusion protein with glutathione S-transferase. Protein Expr Purif (1995) 1.09
[Focal spontaneous colic perforation in term or near-term neonates: rare and potentially insidious]. Arch Pediatr (2011) 1.08
Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res (1988) 1.06
The role of Cys12, Cys17 and Arg18 in the catalytic mechanism of low-M(r) cytosolic phosphotyrosine protein phosphatase. Eur J Biochem (1993) 1.04
Trace elements in winter snow of the Dolomites (Italy): a statistical study of natural and anthropogenic contributions. Chemosphere (2008) 1.03
Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1. Biochem Biophys Res Commun (2002) 1.03
Image enhancement via adaptive unsharp masking. IEEE Trans Image Process (2000) 1.03
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. Biochem Biophys Res Commun (1999) 1.01
Apoptosis and the cell cycle. Cell Mol Biol Res (1994) 1.01
Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci (1988) 1.00
PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase. FEBS Lett (1995) 1.00
The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem (2000) 0.99
Human interleukin-1 beta gene. Gene (1987) 0.98
Aspartic-129 is an essential residue in the catalytic mechanism of the low M(r) phosphotyrosine protein phosphatase. FEBS Lett (1994) 0.97
Changes in Enzyme Levels During Germination of Seeds of Triticum durum. Plant Physiol (1968) 0.97
Stabilisation of alpha-helices by site-directed mutagenesis reveals the importance of secondary structure in the transition state for acylphosphatase folding. J Mol Biol (2000) 0.97
Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J Biol Chem (1994) 0.97
Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease--single center comparison of four different assays. Thromb Haemost (2000) 0.96
Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res (1996) 0.95
c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. Biochem Biophys Res Commun (1997) 0.95
Dephosphorylation of tyrosine phosphorylated synthetic peptides by rat liver phosphotyrosine protein phosphatase isoenzymes. FEBS Lett (1993) 0.94
Horse muscle acyl phosphatase: purification and some properties. Arch Biochem Biophys (1969) 0.94
Looking for residues involved in the muscle acylphosphatase catalytic mechanism and structural stabilization: role of Asn41, Thr42, and Thr46. Biochemistry (1996) 0.94
The occurrence of cholangitis after percutaneous biliary drainage: evaluation of some risk factors. Surgery (1988) 0.93
Nonenzymatic acetylation of histones with acetyl phosphate and acetyl adenylate. Biochemistry (1975) 0.93
Polyphosphoinositide metabolism is rapidly stimulated by activation of a temperature-sensitive mutant of Rous sarcoma virus in rat fibroblasts. Oncogene (1987) 0.92
The low Mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at Tyr131 or Tyr132 by Src kinase. FEBS Lett (1999) 0.92
Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation. Protein Sci (2001) 0.92
A new synthesis of benzoyl phosphate: a substrate for acyl phosphatase assay. Experientia (1976) 0.92
An inducible enhancer controls the expression of the human interleukin 1 beta gene. Cell Growth Differ (1990) 0.92
Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease. Haemophilia (2008) 0.91
Thermodynamics and kinetics of folding of common-type acylphosphatase: comparison to the highly homologous muscle isoenzyme. Biochemistry (1999) 0.91
Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2. J Cancer Res Clin Oncol (1999) 0.90
The molecular basis of the differing kinetic behavior of the two low molecular mass phosphotyrosine protein phosphatase isoforms. J Biol Chem (1996) 0.90
Folding and aggregation are selectively influenced by the conformational preferences of the alpha-helices of muscle acylphosphatase. J Biol Chem (2001) 0.90
The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling. J Biol Chem (1998) 0.90
LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling. Biochem Biophys Res Commun (1997) 0.89
Molecular evidence of triplication in the haptoglobin Johnson variant gene. Hum Genet (1985) 0.89
Arginine-23 is involved in the catalytic site of muscle acylphosphatase. Biochim Biophys Acta (1994) 0.89